Hektas Ticaret T.A.S. (IBSE:HEKTS) decided to acquire ARMA ILAÇ on December 31, 2020.Hektas Ticaret T.A.S. (IBSE:HEKTS) agreed to acquire ARMA ILAÇ from OYAK BIYOTEKNOLOJI for TRY 92 million on July 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.46 TRY | -1.53% | -1.47% | -23.08% |
1st Jan change | Capi. | |
---|---|---|
-23.08% | 1.23B | |
+15.53% | 38.73B | |
-.--% | 11.33B | |
-2.46% | 7.5B | |
+3.38% | 6.67B | |
-1.21% | 6.3B | |
-1.33% | 5.94B | |
-11.01% | 5.38B | |
+29.68% | 5.13B | |
-12.23% | 4.6B |
- Stock Market
- Equities
- HEKTS Stock
- News Hektas Ticaret T.A.S.
- Hektas Ticaret T.A.S. decided to acquire ARMA ILAÇ from OYAK BIYOTEKNOLOJI for TRY 92 million.